Physical symptoms of depression: Unmet needs

Journal of Clinical Psychiatry

Volumn 64, Issue SUPPL. 7, 2003, Pages 5-11

  Greden, John F ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ABDOMINAL PAIN; BACKACHE; BIPOLAR DEPRESSION; CHRONIC PAIN; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFICACY; EARLY DIAGNOSIS; ELECTRONICS; EMOTION; FATIGUE; GENE EXPRESSION; GENETIC PREDISPOSITION; HAMILTON SCALE; HEADACHE; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEREDITY; HUMAN; LIMB PAIN; LONG TERM CARE; MAJOR DEPRESSION; MENTAL HEALTH SERVICE; MORBIDITY; NEUROCHEMISTRY; PATIENT COMPLIANCE; PHYSICAL DISEASE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REMISSION; REVIEW; SCREENING; SEROTONINERGIC TRANSMISSION; SOCIAL PSYCHOLOGY; STRESS; SUSTAINED RELEASE PREPARATION; SYMPTOM; THORAX PAIN;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; COMORBIDITY; COST OF ILLNESS; DELIVERY OF HEALTH CARE; DEPRESSIVE DISORDER; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; NOREPINEPHRINE; PAIN; PRIMARY HEALTH CARE; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0038580882     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Murray CJL, Lopez AD, eds. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, Mass: Harvard University Press; 1996
2. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003;361:653-661
3. Keller MB, Shapiro RW, Kavori PW, et al. Recovery in major depressive disorder: analysis with the life table and regression models. Arch Gen Psychiatry 1982:39;905-910
4. Paykel ES, Ramana R, Cooper Z, et al. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995;25:1171-1180
5. Von Korff M, Simon G. The relationship between pain and depression. Br J Psychiatry 1996;168:101-108
6. Goldberg DP, Bridges K. Somatic presentations of psychiatric illness in primary care setting. J Psychosom Res 1988;32:137-144
7. Greden JF. Recurrent depression and mania: their overwhelming burden. In: Greden JF, ed. Treatment of Recurrent Depression. Washington, DC: APPI; 2001:1-18
8. Kessler RC, McGonagle KA, Nelson CB, et al. Sex and depression in the national comorbidity survey, 2: cohort effects. J Affect Disord 1994;30: 15-26
9. Lepine JP, Gastpar M, Mendlewicz J, et al. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 1997; 12:19-29
10. Pine DS, Cohen P, Gurley D, et al. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 1998;55:56-64
11. Entsuah AR, Huang H, Thase ME. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J Clin Psychiatry 2001;62:869-877
12. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234-241
13. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000;57:925-935
14. Duman RS, Malberg J, Makagawa S, et al. Neuronal plasticity and survival in mood disorders. Biol Psychiatry 2000;48:732-739
15. McEwen BS. Effects of adverse experiences for brain structure and function. Biol Psychiatry 2000;48:721-731
16. Sheline YI, Sanghavi M, Mintum MA, et al. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent depression. J Neurosci 1999;19:5034-5043
17. Kroenke K, Spitzer RL, Williams JB, et al. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994;3:774-779
18. Ruoff GE. Depression in the patient with chronic pain. J Fam Pract 1996; 43(suppl 6):S25-S33
19. Lesse S. The masked depression syndrome: results of a seventeen-year clinical study. Am J Psychother 1983;37:456-475
20. Simon GE, Von Korff M, Piccinelli M, et al. An international study of the relation between somatic symptoms and depression. N Engl J Med 1999;341:658-659
21. Kirmayer LJ, Robbins JM, Dworkind M. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry 1993; 150:734-741
22. Gerber PD, Barrett JA, Oxman TE, et al. The relationship of presenting physical complaints to depressive symptoms in primary care patients. J Gen Intern Med 1992;7:170-173
23. Gallagher RM, Verma S. Managing pain and comorbid depression: a public health challenge. Semin Clin Neuropsychiatry 1999;4:203-220
24. Basabaum AI, Fields HL. Endogenous pain control mechanisms: review hypothesis. Ann Neurol 1978;4:451-462
25. Nelson JC. Synergistic benefits of serotonin and noradrenaline reuptake inhibition. Depress Anxiety 1998;7(suppl 1):5-6
26. Blier P, Abbott FV. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J Psychiatry Neurosci 2001; 26:37-43
27. O'Malley PG, Jackson JL, Santoro J, et al. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 1999; 48:980-990
28. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996;19:179-200
29. Clinical Practice Guideline Number 5: Depression in Primary Care, vol 2. Treatment of Major Depression. Rockville, Md: US Dept Health Human Services, Agency for Health Care Policy and Research; 1993. AHCPR publication 93-0551
30. Doraiswamy PM, Khan ZM, Donahue RM, et al. Quality of life in geriatric depression: a comparison of remitters, partial responders, and nonresponders. Am J Geriatr Psychiatry 2001;9:423-428
31. Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 2002;11:963-971